Advertisements
Feeds:
Posts
Comments

Search Results for 'coronary artery disease (CAD)'


A new mechanism of action to attack in the treatment of coronary artery disease (CAD), Novartis developed Ilaris (canakinumab), a human monoclonal antibody targeting the interleukin-1beta innate immunity pathway Reporter: Aviva Lev-Ari, PhD, RN   Speaking at an ESC press briefing, Ridker said, “This is what personalized predictive medicine is all about.” Once a patient has […]

Read Full Post »


Atherosclerosis Independence: Genetic Polymorphisms of Ion Channels Role in the Pathogenesis of Coronary Microvascular Dysfunction and Myocardial Ischemia (Coronary Artery Disease (CAD)) Reviewer and Co-Curator: Larry H Bernstein, MD, FCAP and Curator: Aviva Lev-Ari, PhD, RN The role of ion channels in Na(+)-K(+)-ATPase: regulation of ion
transport across the plasma membrane has been studied by our Team in […]

Read Full Post »


Stem Cell Therapy for Coronary Artery Disease (CAD) Author and Curator: Larry H. Bernstein, MD, FCAP and Curator: Aviva Lev-Ari, PhD, RN   There is great interest and future promise for stem cell therapy in ischemic heart disease.  This is another report for the active work in cardiology with stem cell therapy by MA Gaballa […]

Read Full Post »


UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active The FDA approved the first ultrathin strut drug-eluting stent, Orsiro, as well as a shelf-stable, premixed vancomycin injection for infective endocarditis and other indications. UPDATED on 3/16/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active Dual antiplatelet therapy with ticagrelor (Brilinta) reduced major adverse cardiovascular events in type 2 diabetes patients with coronary artery disease but no prior heart attack or […]

Read Full Post »


Spectranetics, a Technology Leader in Medical Devices for Coronary Intervention, Peripheral Intervention, Lead Management to be acquired by Philips for 1.9 Billion Euros Reporter and Curator: Aviva Lev-Ari, PhD, RN     BUSINESS NEWS | Wed Jun 28, 2017 | 10:53am BST Philips to buy medical device maker Spectranetics for 1.9 billion euros By Toby Sterling […]

Read Full Post »


Series A: e-Books on Cardiovascular Diseases Series A Content Consultant: Justin D Pearlman, MD, PhD, FACC VOLUME FOUR Regenerative and Translational Medicine The Therapeutic Promise for Cardiovascular Diseases on Amazon since 12/26/2015 http://www.amazon.com/dp/B019UM909A   by   Larry H Bernstein, MD, FCAP, Senior Editor, Author and Curator and Aviva Lev-Ari, PhD, RN, Editor and Curator   Part One: Cardiovascular […]

Read Full Post »


Human Genetics and Childhood Diseases Larry H. Bernstein, Md, FCAP, Curator LPBI     Publication Roundup: HGMD HGMD®, the Human Gene Mutation Database is used by scientists around the world to find information on reported genetic mutations. The papers below use the database to advance our understanding of disease, DNA dynamics, and more. https://www.qiagenbioinformatics.com/blog/translational/publication-roundup-hgmd Local DNA […]

Read Full Post »


Commentary on Biomarkers for Genetics and Genomics of Cardiovascular Disease: : Views by Larry H Bernstein, MD, FCAP   Author: Larry H Bernstein, MD, FCAP This review has examined a compendium of well regarded documents drawn from 248 articles in Circulation Cardiovascular Genetics from March 2010 to March 2013. The large amount of evidence obtained from […]

Read Full Post »

Summary – Volume 4, Part 2: Translational Medicine in Cardiovascular Diseases


Summary – Volume 4, Part 2:  Translational Medicine in Cardiovascular Diseases Author and Curator: Larry H Bernstein, MD, FCAP   We have covered a large amount of material that involves the development, application, and validation of outcomes of medical and surgical procedures that are based on translation of science from the laboratory to the bedside, […]

Read Full Post »


Cardiovascular Diseases, Biomarkers  and Pharmacological Therapy: Curations by Aviva Lev-Ari, PhD, RN, 2006 – 4/2018   Calcium & Cardiovascular Diseases: Contractile Dysfunction, Calcium as Neurotransmitter Sensor Archives of Medicine (AOM) to Publish from “Leaders in Pharmaceutical Business Intelligence (LPBI)” Open Access On-Line Scientific Journal http://pharmaceuticalintelligence.com From our series on Calcium and Cardiovascular Diseases: A Series of Twelve Articles in […]

Read Full Post »

Next »